Investing
Investment Proceeds
Edwards Lifesciences Investment Proceeds increased by 58.2% to $12.5M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 29.4%, from $17.7M to $12.5M. Over 4 years (FY 2021 to FY 2025), Investment Proceeds shows a downward trend with a -18.1% CAGR.
Analysis
StatementCash Flow Statement
SectionInvesting
First reportedQ1 2013
Last reportedQ1 2026May 6, 2026
Metric ID:
proceeds_from_investmentsHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0 | $20M | $68M | $130M | $147.5M | $47M | $95M | $80.5M | $3M | $8M | $6.4M | $9.3M | $15.9M | $25.2M | $7.1M | $17.7M | $14.3M | $22.2M | $7.9M | $12.5M |
| QoQ Change | — | — | +240.0% | +91.2% | +13.5% | -68.1% | +102.1% | -15.3% | -96.3% | +166.7% | -20.0% | +45.3% | +71.0% | +58.5% | -71.8% | +149.3% | -19.2% | +55.2% | -64.4% | +58.2% |
| YoY Change | — | — | — | — | — | +135.0% | +39.7% | -38.1% | -98.0% | -83.0% | -93.3% | -88.4% | +430.0% | +215.0% | +10.9% | +90.3% | -10.1% | -11.9% | +11.3% | -29.4% |
Range$0 – $147.5M
Avg YoY Growth+32.0%
Median YoY Growth-10.1%
Investment Proceeds at Other Companies
Frequently Asked Questions
- What is Edwards Lifesciences's investment proceeds?
- Edwards Lifesciences (EW) reported investment proceeds of $12.5M in Q1 2026.
- How has Edwards Lifesciences's investment proceeds changed year-over-year?
- Edwards Lifesciences's investment proceeds decreased by 29.4% year-over-year, from $17.7M to $12.5M.
- What is the long-term trend for Edwards Lifesciences's investment proceeds?
- Over 4 years (2021 to 2025), Edwards Lifesciences's investment proceeds has grown at a -18.1% compound annual growth rate (CAGR), from $138M to $62.1M.